Table 1.
Baseline characteristics of the two groups.
| Slender 7 Fr sheath group (n = 154) | 6 Fr sheath group (n = 123) | P value | |
|---|---|---|---|
| Age (years) | 61.83 ± 10.64 | 60.64 ± 13.53 | 0.429 |
| Male sex (n, %) | 105 (68.2) | 75 (61) | 0.212 |
| Height (m) | 1.68 ± 0.08 | 1.69 ± 0.09 | 0.401 |
| Weight (kg) | 71.92 ± 10.06 | 71.15 ± 12.19 | 0.578 |
| BMI (kg/m2) | 25.44 ± 2.78 | 24.84 ± 2.97 | 0.083 |
| Hypertension (n, %) | 76 (49.4) | 54 (43.9) | 0.367 |
| Diabetes mellitus (n, %) | 48 (31.2) | 29 (23.6) | 0.161 |
| Dyslipidemia (n, %) | 25 (16.2) | 30 (24.4) | 0.091 |
| Current smoking (n, %) | 35 (22.7) | 36 (29.3) | 0.215 |
| Previous MI (n, %) | 27 (17.5) | 15 (12.2) | 0.218 |
| Previous PCI (n, %) | 49 (31.8) | 29 (23.6) | 0.130 |
| Previous CABG (n, %) | 3 (1.9) | 3 (2.4) | 1.000 |
| Previous stroke (n, %) | 7 (4.5) | 10 (8.1) | 0.217 |
| Previous homolateral radial access (n, %) | 75 (48.7) | 54 (43.9) | 0.426 |
| Peripheral artery disease (n, %) | 5 (3.2) | 10 (8.1) | 0.074 |
| Heparin (IU) | 10191.56 ± 1006.25 | 10115.45 ± 1219.18 | 0.578 |
| Aspirin (n, %) | 154 (100) | 123 (100) | NS |
| P2Y12 inhibitor (n, %) | 154 (100) | 123 (100) | NS |
| Successful radial artery hemostasis (n, %) | 132 (85.7) | 105 (85.4) | 0.935 |
| Creatinine | 69.53 ± 20.62 | 65.97 ± 13.26 | 0.098 |
| GFR (mL/min/1.73 m2) | 87.69 ± 23.38 | 89.79 ± 21.40 | 0.439 |
| LVEF | 61.37 ± 6.55 | 62.89 ± 7.28 | 0.068 |
Values are mean ± standard deviation or n (%).
BMI, body mass index; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; GFR, glomerular filtration rate; LVEF, left ventricular ejection fraction.